Amgen Inc. has been pumping up its biotech drug pipeline, even as it recently fell short of quarterly sales targets, the Los Angeles Times reports.
Amgen Inc. has been pumping up its biotech drug pipeline, even as it recently fell short of quarterly sales targets, the Los Angeles Times reports.